Placenta Lucchini Therapy: Revitalizing Health from Within
Placenta-based therapies have long been associated with regenerative medicine, and among the most widely recognized in clinical use is Placenta Lucchini Therapy. Originating from advanced cellular research and developed in Switzerland, this therapy uses placental extract and is offered in some wellness and aesthetic settings. At Live More Clinic, Placenta Lucchini is prescription-only and is given only after a doctor’s assessment. As set out below, the clinical evidence for placental extract is limited.
What Is Placenta Lucchini?
Placenta Lucchini is a biologically active therapy derived from human or animal placental tissue—most commonly sheep placenta—processed under sterile and pharmaceutical-grade conditions. It contains a mix of biological components including peptides, amino acids, enzymes, vitamins and growth factors. What these components do when given as an injection is still being studied, and firm conclusions are limited.
What the research looks at
The clinical evidence for placental extract is limited and comes mainly from small trials of human placental extract. The most relevant findings are in two areas:
- Fatigue. A randomised, double-blind, placebo-controlled trial reported reduced fatigue in people with chronic fatigue syndrome (Park et al., 2016).
- Menopausal symptoms. A randomised, placebo-controlled trial in middle-aged women reported improvement in menopausal symptoms and fatigue (Kong et al., 2008).
These are small, early studies. Live More does not claim placental extract treats any specific disease, and other uses discussed online are not well supported by robust clinical evidence. Whether it may suit you is a decision to make with a doctor.
Who Can Benefit from Placenta Lucchini?
Placenta Lucchini is particularly helpful for individuals who are:
- Experiencing ongoing fatigue
- Undergoing hormonal shifts (e.g. menopause or andropause)
- Recovering from illness, surgery, or physical stress
- Curious about it and want a doctor’s assessment first
- Looking to support energy, focus and general wellbeing
While generally well tolerated, it is not recommended for individuals with active cancers, autoimmune flare-ups, or those who are pregnant or breastfeeding without medical supervision.
How Is It Administered?
Placenta Lucchini is administered via intramuscular injection, typically into the upper arm or gluteal region. Depending on the patient’s goals and health status, a course may consist of one to three injections per week over a 4–6 week period. In some cases, it can be integrated into a broader wellness protocol alongside other therapies where appropriate.
What to Expect During and After the Therapy
During administration, patients experience only mild discomfort similar to a routine injection. The treatment is quick, requiring just a few minutes in the clinic.
After the session, patients may feel:
- Some people describe a subtle increase in energy within the first days, though responses vary
- Possible changes in sleep quality and recovery, which vary between individuals
- Possible changes in skin texture over several sessions
- Some people report changes in mood and mental clarity
Mild soreness at the injection site is possible but typically resolves within 24 hours. As with all therapies offered at Live More Clinic, treatments are tailored to the individual and monitored by our medical team, and we discuss the current evidence and limitations with you.
Is Placenta Lucchini Right for You?
If you're considering Placenta Lucchini, it is worth discussing it with a doctor first. Schedule a consultation with our clinical team to determine if this therapy aligns with your health goals.
- Park, S. B., et al. (2016).
“Human Placental Extract as a Subcutaneous Injection Is Effective in Chronic Fatigue Syndrome: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.”
Biological & Pharmaceutical Bulletin, 39(5), 674–679.
https://pubmed.ncbi.nlm.nih.gov/26911970/ - Kong, M. H., et al. (2008).
“Effect of human placental extract on menopausal symptoms, fatigue, and risk factors for cardiovascular disease in middle-aged Korean women.”
Menopause, 2008.
https://pubmed.ncbi.nlm.nih.gov/18090035/